STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) saw a significant drop in short interest in April. As of April 15th, there was short interest totalling 157,200 shares, a drop of 27.0% from the March 31st total of 215,200 shares. Currently, 0.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 26,000 shares, the short-interest ratio is currently 6.0 days.

STRATA Skin Sciences Stock Performance

STRATA Skin Sciences stock traded down $0.01 on Friday, reaching $0.51. The company’s stock had a trading volume of 7,598 shares, compared to its average volume of 31,487. STRATA Skin Sciences has a twelve month low of $0.26 and a twelve month high of $1.14. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.06. The business’s fifty day moving average price is $0.50 and its 200 day moving average price is $0.52.

STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings data on Wednesday, March 27th. The medical device company reported ($0.04) earnings per share for the quarter. STRATA Skin Sciences had a negative net margin of 32.47% and a negative return on equity of 52.50%. The company had revenue of $8.69 million during the quarter. As a group, equities research analysts forecast that STRATA Skin Sciences will post -0.19 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of SSKN. Azzad Asset Management Inc. ADV boosted its stake in STRATA Skin Sciences by 289.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock valued at $25,000 after acquiring an additional 49,800 shares during the last quarter. Chicago Partners Investment Group LLC grew its stake in shares of STRATA Skin Sciences by 162.0% during the fourth quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock worth $33,000 after purchasing an additional 39,706 shares during the period. Finally, 22NW LP increased its holdings in STRATA Skin Sciences by 56.1% in the third quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock valued at $3,195,000 after purchasing an additional 1,930,693 shares during the last quarter. 32.43% of the stock is currently owned by institutional investors.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.